The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Ellingboe, Anna
    Private Equity born in August 1994
    Individual (2 offsprings)
    Officer
    2025-01-24 ~ now
    OF - Director → CIF 0
  • 2
    Nordhoy, Erik
    President born in February 1964
    Individual (1 offspring)
    Officer
    2024-11-12 ~ now
    OF - Director → CIF 0
    Mr Erik Nordhoy
    Born in February 1964
    Individual (1 offspring)
    Person with significant control
    2024-12-31 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
Ceased 8
  • 1
    Krichevsky, Eugene
    Investment Partner born in September 1975
    Individual
    Officer
    2024-11-12 ~ 2025-01-24
    OF - Director → CIF 0
  • 2
    Westwood, Tracy
    Individual
    Officer
    2012-03-21 ~ 2017-04-24
    OF - Secretary → CIF 0
  • 3
    Gray, Alexander Wolfgang
    Company Director born in January 1970
    Individual
    Officer
    2007-08-30 ~ 2008-04-14
    OF - Director → CIF 0
  • 4
    Kerridge, Stephen
    Director born in June 1959
    Individual (8 offsprings)
    Officer
    2009-06-23 ~ 2010-04-09
    OF - Director → CIF 0
  • 5
    Rea, Michael
    Marketing Consultant born in December 1965
    Individual (1 offspring)
    Officer
    2000-12-07 ~ 2024-11-12
    OF - Director → CIF 0
    Michael Rea
    Born in December 1965
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ 2024-11-12
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 6
    Rea, Clare Holly
    Director born in December 1972
    Individual (2 offsprings)
    Officer
    2000-12-07 ~ 2007-08-30
    OF - Director → CIF 0
    Rea, Clare Holly, Mrs.
    Chief People Officer born in December 1972
    Individual (2 offsprings)
    Officer
    2023-05-30 ~ 2024-11-12
    OF - Director → CIF 0
    Rea, Clare Holly
    Individual (2 offsprings)
    Officer
    2000-12-07 ~ 2007-08-30
    OF - Secretary → CIF 0
    2009-09-29 ~ 2012-03-21
    OF - Secretary → CIF 0
    Clare Holly Rea
    Born in December 1972
    Individual (2 offsprings)
    Person with significant control
    2016-04-06 ~ 2023-11-02
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 7
    Bradford, Paul
    Company Director born in June 1966
    Individual (12 offsprings)
    Officer
    2007-08-30 ~ 2009-09-30
    OF - Director → CIF 0
    Bradford, Paul
    Individual (12 offsprings)
    Officer
    2007-08-30 ~ 2009-09-30
    OF - Secretary → CIF 0
  • 8
    IGP CORPORATE NOMINEES LTD. - now
    THE COMPANY STORE UK SERVICES LIMITED - 1996-11-08
    19 Kathleen Road, London
    Dissolved Corporate (1 parent, 12 offsprings)
    Equity (Company account)
    9,001 GBP2021-03-31
    Officer
    2000-12-07 ~ 2000-12-07
    PE - Nominee Secretary → CIF 0
parent relation
Company in focus

IDEAPHARMA LTD

Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Average Number of Employees
232023-01-01 ~ 2023-12-31
202022-01-01 ~ 2022-12-31
Intangible Assets
19,857 GBP2023-12-31
61,768 GBP2022-12-31
Property, Plant & Equipment
33,524 GBP2023-12-31
58,107 GBP2022-12-31
Fixed Assets - Investments
339,900 GBP2023-12-31
339,900 GBP2022-12-31
Fixed Assets
393,281 GBP2023-12-31
459,775 GBP2022-12-31
Debtors
Current
1,640,614 GBP2023-12-31
2,283,275 GBP2022-12-31
Cash at bank and in hand
7,053 GBP2023-12-31
14,592 GBP2022-12-31
Current Assets
1,647,667 GBP2023-12-31
2,297,867 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-823,736 GBP2023-12-31
-1,181,889 GBP2022-12-31
Net Current Assets/Liabilities
823,931 GBP2023-12-31
1,115,978 GBP2022-12-31
Total Assets Less Current Liabilities
1,217,212 GBP2023-12-31
1,575,753 GBP2022-12-31
Creditors
Non-current, Amounts falling due after one year
-41,667 GBP2022-12-31
Net Assets/Liabilities
1,209,927 GBP2023-12-31
1,520,745 GBP2022-12-31
Equity
Called up share capital
943 GBP2023-12-31
790 GBP2022-12-31
790 GBP2022-01-01
Share premium
403,288 GBP2023-12-31
391,032 GBP2022-12-31
391,032 GBP2022-01-01
Retained earnings (accumulated losses)
805,696 GBP2023-12-31
1,128,923 GBP2022-12-31
1,196,678 GBP2022-01-01
Equity
1,209,927 GBP2023-12-31
1,520,745 GBP2022-12-31
1,588,500 GBP2022-01-01
Profit/Loss
Retained earnings (accumulated losses)
-221,751 GBP2023-01-01 ~ 2023-12-31
167,158 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
-221,751 GBP2023-01-01 ~ 2023-12-31
167,158 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-221,751 GBP2023-01-01 ~ 2023-12-31
167,158 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
-221,751 GBP2023-01-01 ~ 2023-12-31
167,158 GBP2022-01-01 ~ 2022-12-31
Dividends Paid
Retained earnings (accumulated losses)
-101,476 GBP2023-01-01 ~ 2023-12-31
-234,913 GBP2022-01-01 ~ 2022-12-31
Dividends Paid
-101,476 GBP2023-01-01 ~ 2023-12-31
-234,913 GBP2022-01-01 ~ 2022-12-31
Issue of Equity Instruments
Called up share capital
153 GBP2023-01-01 ~ 2023-12-31
Issue of Equity Instruments
12,409 GBP2023-01-01 ~ 2023-12-31
Equity - Income/Expense Recognised Directly
Called up share capital
153 GBP2023-01-01 ~ 2023-12-31
Retained earnings (accumulated losses)
-101,476 GBP2023-01-01 ~ 2023-12-31
-234,913 GBP2022-01-01 ~ 2022-12-31
Equity - Income/Expense Recognised Directly
-89,067 GBP2023-01-01 ~ 2023-12-31
-234,913 GBP2022-01-01 ~ 2022-12-31
Intangible Assets - Gross Cost
Development expenditure
103,287 GBP2023-12-31
103,287 GBP2022-12-31
Computer software
179,470 GBP2023-12-31
179,470 GBP2022-12-31
Intangible Assets - Gross Cost
282,757 GBP2023-12-31
282,757 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
103,287 GBP2023-12-31
103,287 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
262,900 GBP2023-12-31
220,989 GBP2022-12-31
Intangible Assets - Increase From Amortisation Charge for Year
41,911 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Furniture and fittings
139,428 GBP2023-12-31
135,260 GBP2022-12-31
Other
32,520 GBP2023-12-31
32,520 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
171,948 GBP2023-12-31
167,780 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Furniture and fittings
91,608 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
109,673 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings, Owned/Freehold
17,912 GBP2023-01-01 ~ 2023-12-31
Owned/Freehold
28,751 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
109,520 GBP2023-12-31
Other
28,904 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
138,424 GBP2023-12-31
Property, Plant & Equipment
Furniture and fittings
29,908 GBP2023-12-31
43,652 GBP2022-12-31
Other
3,616 GBP2023-12-31
14,455 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
105,428 GBP2023-12-31
764,149 GBP2022-12-31
Amounts Owed by Group Undertakings
Current
974,365 GBP2023-12-31
903,992 GBP2022-12-31
Other Debtors
Current
484,168 GBP2023-12-31
335,319 GBP2022-12-31
Prepayments/Accrued Income
Current
76,653 GBP2023-12-31
279,815 GBP2022-12-31
Bank Overdrafts
-224,314 GBP2023-12-31
-72,767 GBP2022-12-31
Cash and Cash Equivalents
-217,261 GBP2023-12-31
-58,175 GBP2022-12-31
Bank Overdrafts
Current
224,314 GBP2023-12-31
72,767 GBP2022-12-31
Bank Borrowings
Current
41,667 GBP2023-12-31
100,000 GBP2022-12-31
Other Remaining Borrowings
Current
248,333 GBP2023-12-31
337,500 GBP2022-12-31
Trade Creditors/Trade Payables
Current
57,644 GBP2023-12-31
302,777 GBP2022-12-31
Corporation Tax Payable
Current
30,211 GBP2023-12-31
32,329 GBP2022-12-31
Taxation/Social Security Payable
Current
81,927 GBP2023-12-31
85,951 GBP2022-12-31
Other Creditors
Current
25,996 GBP2023-12-31
60,222 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
113,644 GBP2023-12-31
190,343 GBP2022-12-31
Creditors
Current
823,736 GBP2023-12-31
1,181,889 GBP2022-12-31
Bank Borrowings
Non-current
41,667 GBP2022-12-31
Creditors
Non-current
41,667 GBP2022-12-31
Bank Borrowings
Current, Amounts falling due within one year
41,667 GBP2023-12-31
100,000 GBP2022-12-31
Total Borrowings
Current, Amounts falling due within one year
290,000 GBP2023-12-31
437,500 GBP2022-12-31
Bank Borrowings
Non-current, Between one and two years
41,667 GBP2022-12-31
Total Borrowings
290,000 GBP2023-12-31
479,167 GBP2022-12-31
Net Deferred Tax Liability/Asset
-7,285 GBP2023-12-31
-13,341 GBP2022-12-31
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
6,056 GBP2023-01-01 ~ 2023-12-31
Deferred Tax Liabilities
Accelerated tax depreciation
-7,285 GBP2023-12-31
-13,341 GBP2022-12-31
Related profiles found in government register
  • IDEAPHARMA LTD
    Info
    Registered number 04121191
    The Scalpel 18th Floor, 52 Lime Street, London EC3M 7AF
    Private Limited Company incorporated on 2000-12-07 (24 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-06-21
    CIF 0
  • IDEAPHARMA LTD
    S
    Registered number 04121191
    Cranfield Innovation Centre, University Way, Cranfield University Technology Park, Cranfield, Beds, United Kingdom, MK43 0BT
    Limited By Shares in Companies House, England And Wales
    CIF 1
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
Ceased 1
  • Q 2 AUDIT LIMITED - 2020-10-30
    2Q LIMITED - 2004-09-06
    55 - 56 Russell Square, Holborn, London, England
    Active Corporate (2 parents)
    Equity (Company account)
    -539,823 GBP2023-12-31
    Person with significant control
    2016-04-06 ~ 2021-04-01
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.